Nesina 12.5 MG Oral Tablet
- RxCUI
- 1368036
- RxNorm name
- Nesina 12.5 MG Oral Tablet
- Display name
- Nesina 12.5 MG Oral Tablet
- Full name
- Nesina 12.5 MG Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:12
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nesina | ALOGLIPTIN | Takeda Pharmaceuticals America, Inc. | a3768c7e-aa4c-44d3-bc53-43bb7346c0b0 | 2025-02-28 | Warnings, Adverse reactions | 1368036 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a3768c7e-aa4c-44d3-bc53-43bb7346c0b0 | Nesina 12.5 MG Oral Tablet | SY | 22 | These highlights do not include all the information needed to use NESINA ® safely and effectively. See full prescribing information for NESINA. NESINA (alogliptin) tablets, for oral use Initial U.S. Approval: 2013 | 20250228 |
| a3768c7e-aa4c-44d3-bc53-43bb7346c0b0 | alogliptin 12.5 MG Oral Tablet [Nesina] | SBD | 22 | These highlights do not include all the information needed to use NESINA ® safely and effectively. See full prescribing information for NESINA. NESINA (alogliptin) tablets, for oral use Initial U.S. Approval: 2013 | 20250228 |
| a3768c7e-aa4c-44d3-bc53-43bb7346c0b0 | Nesina 12.5 MG (as alogliptin benzoate 17 MG) Oral Tablet | SY | 22 | These highlights do not include all the information needed to use NESINA ® safely and effectively. See full prescribing information for NESINA. NESINA (alogliptin) tablets, for oral use Initial U.S. Approval: 2013 | 20250228 |
| a3768c7e-aa4c-44d3-bc53-43bb7346c0b0 | Nesina 12.5 MG Oral Tablet | PSN | 22 | These highlights do not include all the information needed to use NESINA ® safely and effectively. See full prescribing information for NESINA. NESINA (alogliptin) tablets, for oral use Initial U.S. Approval: 2013 | 20250228 |